Production (Stage)
eXoZymes, Inc.
EXOZ
$13.15
-$0.8055-5.77%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 1.38M | 1.35M | 888.20K | 1.09M | 730.90K |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 1.95M | 1.98M | 1.61M | 1.33M | 1.01M |
Operating Income | -1.95M | -1.98M | -1.61M | -1.33M | -1.01M |
Income Before Tax | -1.86M | -1.84M | -1.66M | -1.36M | -1.01M |
Income Tax Expenses | -- | -2.10K | -- | 2.10K | -- |
Earnings from Continuing Operations | -1.86M | -1.84M | -1.66M | -1.36M | -1.01M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -1.86M | -1.84M | -1.66M | -1.36M | -1.01M |
EBIT | -1.95M | -1.98M | -1.61M | -1.33M | -1.01M |
EBITDA | -1.88M | -1.92M | -1.54M | -1.26M | -945.70K |
EPS Basic | -0.22 | -0.24 | -0.26 | -0.22 | -0.16 |
Normalized Basic EPS | -0.14 | -0.15 | -0.17 | -0.14 | -0.10 |
EPS Diluted | -0.22 | -0.24 | -0.26 | -0.22 | -0.16 |
Normalized Diluted EPS | -0.14 | -0.15 | -0.17 | -0.14 | -0.10 |
Average Basic Shares Outstanding | 8.37M | 7.50M | 6.25M | 6.25M | 6.25M |
Average Diluted Shares Outstanding | 8.37M | 7.50M | 6.25M | 6.25M | 6.25M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |